Massmutual Trust CO Fsb Neurocrine Biosciences Inc Transaction History
Massmutual Trust CO Fsb
- $3.48 Billion
- Q3 2024
A detailed history of Massmutual Trust CO Fsb transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 374 shares of NBIX stock, worth $47,561. This represents 0.0% of its overall portfolio holdings.
Number of Shares
374
Previous 512
26.95%
Holding current value
$47,561
Previous $70,000
38.57%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NBIX
# of Institutions
617Shares Held
94.7MCall Options Held
583KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.28 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$586 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$314 Million0.6% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.9MShares$241 Million4.37% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...